Free Trial

HUTCHMED (LON:HCM) Share Price Passes Below Two Hundred Day Moving Average - Here's What Happened

HUTCHMED logo with Medical background

HUTCHMED (China) Limited (LON:HCM - Get Free Report) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 266.10 ($3.37) and traded as low as GBX 212 ($2.69). HUTCHMED shares last traded at GBX 216 ($2.74), with a volume of 2,757 shares changing hands.

HUTCHMED Price Performance

The business's 50-day moving average price is GBX 231.31 and its 200 day moving average price is GBX 264.37. The stock has a market capitalization of £2.78 billion, a PE ratio of -65.34 and a beta of 0.76. The company has a debt-to-equity ratio of 11.97, a quick ratio of 2.97 and a current ratio of 2.81.

HUTCHMED Company Profile

(Get Free Report)

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).

See Also

Should You Invest $1,000 in HUTCHMED Right Now?

Before you consider HUTCHMED, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HUTCHMED wasn't on the list.

While HUTCHMED currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines